Dinesh Vyas

Dinesh Vyas

Auto-generated profile, based on publicly available information

Dinesh Vyas

Department of Surgery, California Northstate University College of Medicine, Elk Grove, CA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MGMamie Gao
Mamie Gao
AZAllen Zhong
Allen Zhong
NPNeil Patel
Neil Patel
CAChiraag Alur
Chiraag Alur
DVDinesh Vyas
Dinesh Vyas
RNA sequencing is the use of high throughput next generation sequencing technology to survey, characterize, and quantify the transcriptome of a genome. RNA sequencing has been used to analyze the pathogenesis of several malignancies such melanoma, lung cancer, and colorectal cancer. RNA sequencing can identify differential expression of genes (DEG’s), mutated genes, fusion genes, and gene isoforms in disease states. RNA sequencing has been used in the investigation of several colorectal diseases such as colorectal cancer, inflammatory bowel disease (ulcerative colitis and Crohn’s disease), and irritable bowel syndrome.

21 January 2021 in World Journal of Gastroenterology
Verified
Journal Article
Open access
CHChelsea V Hayman
Chelsea V Hayman
DVDinesh Vyas
Dinesh Vyas
Screening colonoscopy: The present and the future

21 February 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
ABArchana Balakrishnan
Archana Balakrishnan
AVArpita Vyas
Arpita Vyas
KDKaivalya Deshpande
Kaivalya Deshpande
DVDinesh Vyas
Dinesh Vyas
Colorectal cancer accounts for a significant proportion of cancer deaths worldwide. The need to develop more chemotherapeutic agents to combat this disease is critical. Cyclin dependent kinases (CDKs), along with its binding partner cyclins, serve to control the growth of cells through the cell cycle. A new class of drugs, termed CDK inhibitors, has been studied in preclinical and now clinical trials. These inhibitors are believed to act as an anti-cancer drug by blocking CDKs to block the uncontrolled cellular proliferation that is hallmark of cancers like colorectal cancer. CDK article provides overview of the emerging drug class of CDK inhibitors and provides a list of ones that are currently in clinical trials.

1 April 2023 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
JYJihyun Yun
Jihyun Yun
KUKayla Umemoto
Kayla Umemoto
WWWenjia Wang
Wenjia Wang
DVDinesh Vyas
Dinesh Vyas
Purpose: Reporting sharps injuries is crucial for healthcare worker occupational safety. However, these incidents are often underreported, thus posing potentially dangerous working environments. Previous small and limited studies have quantified this underreporting in specific groups of healthcare workers. This study aims to expand on these studies by further quantifying sharps injury incidences through a national study, thus better understanding healthcare reporting behaviors and the reasons for underreporting. Patients and Methods: This is a national, multi-center, cross-sectional study conducted via an online anonymous survey distributed through email among United States attending physicians, fellows, residents, medical students, and nurses of all specialties (ie, surgery, medicine, pediatrics). Data analysis used descriptive statistics and regressive modeling with significance defined as p< 0.05. Results: Of over 3000 surveys emailed, 460 (15.3%) healthcare workers responded. The most vulnerable cohort to report sharps injuries were medical students (0.87 injuries per year ± 0.69, n=92) and Postgraduate Year (PGY) 1 (0.67± 0.81, n=71), PGY2 (0.86±-0.82, n=48), and PGY3 (0.92± 0.8, n=45) resident physicians. Healthcare workers in surgical fields reported significantly higher likelihoods (odds ratio=4.61, p< 0.001, 95% confidence interval 2.83– 7.26) of sharps injuries. Medical students reported sharps injuries the least (40%) and nurses reported sharps injuries the most frequently (71%). The three most common reasons for not reporting sharps injuries included (1) healthcare workers perceiving low infection risk based on patient medical history, (2) fear of peer perception, and (3) belief of lack of reporting utility or that reporting is inconsequential. Conclusion: Medical students and physicians early in training, especially those in surgical fields, are more vulnerable to sharps injuries, but are less likely to report, while nurses are the most likely to report. Dedicated sharps training, education to reduce stigma around injury, and implementing a simplified reporting process may help encourage reporting as well as consistency in reporting, leading to improved workplace safety.

1 June 2016 in Journal of Surgical Research
Verified
Journal Article
Closed access
DVDinesh Vyas
Dinesh Vyas
MHMichael Hollis
Michael Hollis
RARohit Abraham
Rohit Abraham
NRNeeti Rustagi
Neeti Rustagi
SCSiddharth Chandra
Siddharth Chandra
RPRanabir Pal
Ranabir Pal

1 December 2015 in American Journal of Robotic Surgery
Verified
Journal Article
Closed access
DVDinesh Vyas
Dinesh Vyas
SCSean Cronin
Sean Cronin
The peer review processes as outlined in the Health Care Quality Improvement Act (HCQIA) is meant ensure quality standard of care through a self-policing mechanism by the medical community. This process grants immunity for people filing a peer review, which is meant to protect whistleblowers. However, it also creates a loophole that can be used maliciously to hinder competition. This is accentuated when surgeons are integrating new technologies, such as robotic surgery, into their practice. With more than 2000 da Vinci robots in use and more than 300 new units being shipped each year, robotic surgery has become a mainstay in the surgical field. The applications for robots continue to expand as surgeons discover their expanding capability. We need a better peer review process. That ensures the peer review is void of competitive bias. Peer reviewers need to be familiar with the procedure and the technology. The current process could stymie innovation in the name of competition.